Syneos Health and Medable have announced a partnership to deliver decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while also aiming to improving patient access and experiences.
Syneos Health will gain access to Medable’s digital platform as well as deliver a decentralized digital solution to Syneos Health customers tailored to the specific attributes and requirements for conducting non-interventional research.
Medable will also now be part of the Syneos Health Dynamic Assembly network, an open ecosystem of data and technology collaborators committed to delivering solutions designed to strategically address the nuances of each customer engagement.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.